The estimated Net Worth of Bret Schwartzhoff is at least $633 mil dollars as of 7 November 2017. Mr. Schwartzhoff owns over 9,500 units of Apollo Endosurgery Inc stock worth over $156,310 and over the last 8 years he sold APEN stock worth over $0. In addition, he makes $476,556 as Vice President - North America Sales and Global Marketing at Apollo Endosurgery Inc.
Sign up
Mr. Schwartzhoff APEN stock SEC Form 4 insiders trading
Bret has made over 1 trades of the Apollo Endosurgery Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 9,500 units of APEN stock worth $40,280 on 7 November 2017.
The largest trade he's ever made was buying 9,500 units of Apollo Endosurgery Inc stock on 7 November 2017 worth over $40,280. On average, Bret trades about 1,188 units every 0 days since 2016. As of 7 November 2017 he still owns at least 15,631 units of Apollo Endosurgery Inc stock.
You can see the complete history of Mr. Schwartzhoff stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Bret Schwartzhoff biography
Bret Schwartzhoff serves as Vice President - North America Sales and Global Marketing of the Company. Since December 2017, Mr. Schwartzhoff has served as Vice President, North America Sales and Global Marketing of Apollo, previously holding positions of Vice President of U.S. Sales and Global Marketing from December 2016 to December 2017, and from December 2014 to December 2015, he served as Apollo's Vice President U.S. Sales. From 2011 to 2014, Mr. Schwartzhoff served as Vice President of Marketing, Sports Medicine at ArthroCare Corporation and Smith & Nephew plc, which acquired ArthroCare, both medical device companies. Mr. Schwartzhoff holds a B.S. in Business from Mankato State University and an M.B.A. from Wake Forest University.
What is the salary of Bret Schwartzhoff?
As the Vice President - North America Sales and Global Marketing of Apollo Endosurgery Inc, the total compensation of Bret Schwartzhoff at Apollo Endosurgery Inc is $476,556. There are 3 executives at Apollo Endosurgery Inc getting paid more, with Christopher Gostout having the highest compensation of $1,156,870.
How old is Bret Schwartzhoff?
Bret Schwartzhoff is 48, he's been the Vice President - North America Sales and Global Marketing of Apollo Endosurgery Inc since 2017. There are 16 older and 1 younger executives at Apollo Endosurgery Inc. The oldest executive at Apollo Endosurgery Inc is Dr. Christopher J. Gostout, 70, who is the Co-Founder & Chief Medical Officer.
What's Bret Schwartzhoff's mailing address?
Bret's mailing address filed with the SEC is 1120 S Capital of Texas Hwy #300, Austin, TX 78746, USA.
Insiders trading at Apollo Endosurgery Inc
Over the last 12 years, insiders at Apollo Endosurgery Inc have traded over $3,882,241 worth of Apollo Endosurgery Inc stock and bought 10,717,094 units worth $45,588,363 . The most active insiders traders include Holdings A/S Novo, Neil Gagnon y R Kent Jr Mc Gaughy. On average, Apollo Endosurgery Inc executives and independent directors trade stock every 41 days with the average trade being worth of $2,726,880. The most recent stock trade was executed by Jeffrey G. Black on 25 February 2022, trading 40,000 units of APEN stock currently worth $229,200.
What does Apollo Endosurgery Inc do?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
What does Apollo Endosurgery Inc's logo look like?
Complete history of Mr. Schwartzhoff stock trades at Apollo Endosurgery Inc
Apollo Endosurgery Inc executives and stock owners
Apollo Endosurgery Inc executives and other stock owners filed with the SEC include:
-
Christopher Gostout,
Chief Medical Officer -
Todd Newton,
Chief Executive Officer, Director -
John J. Molesphini,
Exec. VP of Operations -
Bret Schwartzhoff,
Vice President - North America Sales and Global Marketing -
Stefanie Cavanaugh,
Chief Financial Officer, Secretary -
K. Todd Newton,
Consultant -
Bret Schwartzhoff,
VP, US Sales & Global Marketing -
Julie Shimer,
Independent Director -
Bruce Robertson,
Independent Director -
David Pacitti,
Independent Director -
R. Kent McGaughy,
Independent Director -
William McClellan,
Independent Director -
John Barr,
Independent Director -
Rick Anderson,
Independent Director -
John Molesphini,
Executive Vice President - Operations -
Dr. Christopher J. Gostout M.D.,
Co-Founder & Chief Medical Officer -
Jeffrey G. Black,
Chief Financial Officer -
Dr. Pankaj Jay Pasricha FACP, M.D., MBBS,
Co-Founder -
Dr. Christopher J. Gostout,
Co-Founder & Chief Medical Officer -
Sydney Chung M.D.,
Co-Founder and Innovation Partner -
Dr. Peter Benjamin Cotton M.D.,
Co-Founder and Innovation Partner -
Dr. Robert Hawes M.D.,
Co-Founder and Innovation Partner -
Anthony Kalloo M.D.,
Co-Founder and Innovation Partner -
Dr. Sergey Kantsevoy M.D.,
Co-Founder and Innovation Partner -
Charles S. McKhann,
CEO, Pres & Director -
Sciences Ii L Pptv Iv, L.P....,
-
Ventures Llc Remeditex,
10% owner -
Richard J Meelia,
Director -
Dennis L. Mc Williams,
President, CCO -
Ventures Endosurgery, Llc...,
10% owner -
Holdings A/S Novo,
10% owner -
John W Creecy,
Director -
Charles Tribie,
Executive V.P. of Operations -
Chas Mc Khann,
President and CEO -
Sciences Ii L Pptv Iv, L.P....,
-
Sciences Ii L Pptv Iv, L.P....,
-
Capital, L.P. Stonepine,
10% owner -
Sciences Ii L Pptv Special ...,
-
Inc Cpmg,
-
James W Jr Traweek,
-
Neil Gagnon,
10% owner -
Sciences Ii L Pptv Iv, L.P....,
-
Inc Desai Antal Rohit Cpmg,
-
Matthew S Crawford,
10% owner -
Jeffrey G. Black,
Chief Financial Officer -
Mike Gutteridge,
VP, Int'l Sales and Marketing -
Sharon O'keefe,
Director -
Jeannette Bankes,
Director